The genomic landscape of lung cancer in individuals who have never smoked has not been well defined. New research indicates that most of these tumors may occur as a result of natural processes within the body. In addition, 3 distinct subtypes of tumors were identified, which could have important treatment implications. The findings are available in Nature Genetics: Genomic and evolutionary classification of lung cancer in never smokers. The research, the Sherlock-Lung study, sponsored by the National Cancer Institute (NCI), is managed under a support service contract between Westat and the NCI Integrative Tumor Epidemiology Branch (ITEB). Westat’s Jennifer Rosenbaum, M.P.H., is the Sherlock-Lung study manager and a coauthor of the article; Sara Glashofer, M.S., is the project director of the ITEB support services contract.
Learn more on how Westat is supporting research by searching for causes of lung cancer in never-smokers with the Sherlock-Lung study | Westat